Acelrx Pharmaceuticals reported $72.26M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 72.26M 7.32M
Acura Pharmaceuticals ACUR:US 1.9M 22K
Baxter International BAX:US $ 19807M 125M
Becton, Dickinson and BDX:US $ 53866M 467M
Biodelivery Sciences International BDSI:US $ 256.07M 5.74M
Cara Therapeutics CARA:US $ 225.09M 3.64M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Intra Cellular Therapies ITCI:US $ 556.98M 68.72M
Pain Therapeutics PTIE:US $ 274.25M 7.06M
Smiths SMIN:LN 5.34B 236M
Teva Pharmaceutical TEVA:IT 47.85B 1.34B
Xeris Pharmaceuticals Inc XERS:US $ 131.26M 20.24M
Zogenix ZGNX:US $ 496.99M 43.09M